These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3515180)

  • 21. Plasmodium falciparum: isolation and characterization of a 55-kDa protease with a cathepsin D-like activity from P. falciparum.
    Bailly E; Savel J; Mahouy G; Jaureguiberry G
    Exp Parasitol; 1991 Apr; 72(3):278-84. PubMed ID: 2015866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parasite proteases and antimalarial activities of protease inhibitors.
    Vander Jagt DL; Caughey WS; Campos NM; Hunsaker LA; Zanner MA
    Prog Clin Biol Res; 1989; 313():105-18. PubMed ID: 2675111
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of ferriprotoporphyrin IX and chloroquine on phospholipid monolayers and the possible implications to antimalarial activity.
    Ginsburg H; Demel RA
    Biochim Biophys Acta; 1983 Jul; 732(1):316-9. PubMed ID: 6871197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs.
    Famin O; Krugliak M; Ginsburg H
    Biochem Pharmacol; 1999 Jul; 58(1):59-68. PubMed ID: 10403519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolysis of mouse erythrocytes by ferriprotoporphyrin IX and chloroquine. Chemotherapeutic implications.
    Chou AC; Fitch CD
    J Clin Invest; 1980 Oct; 66(4):856-8. PubMed ID: 7419723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.
    Rosenthal PJ; McKerrow JH; Aikawa M; Nagasawa H; Leech JH
    J Clin Invest; 1988 Nov; 82(5):1560-6. PubMed ID: 3053784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of 37-kilodalton proteases from Plasmodium falciparum and Plasmodium berghei which cleave erythrocyte cytoskeletal components.
    Deguercy A; Hommel M; Schrével J
    Mol Biochem Parasitol; 1990 Jan; 38(2):233-44. PubMed ID: 2183048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The state of ferriprotoporphyrin IX in malaria pigment.
    Fitch CD; Kanjananggulpan P
    J Biol Chem; 1987 Nov; 262(32):15552-5. PubMed ID: 3119578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferriprotoporphyrin IX: role in chloroquine susceptibility and resistance in malaria.
    Fitch CD
    Prog Clin Biol Res; 1989; 313():45-52. PubMed ID: 2675116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1.
    Fräki JE
    Arch Dermatol Res (1975); 1976 Jun; 255(3):317-30. PubMed ID: 8017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.
    Gluzman IY; Francis SE; Oksman A; Smith CE; Duffin KL; Goldberg DE
    J Clin Invest; 1994 Apr; 93(4):1602-8. PubMed ID: 8163662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heme polymerase: modulation by chloroquine treatment of a rodent malaria.
    Chou AC; Fitch CD
    Life Sci; 1992; 51(26):2073-8. PubMed ID: 1474861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of chloroquine-induced redistribution of a neutral aminopeptidase to hemoglobin accumulation in malaria parasites.
    Fitch CD; Cai GZ; Chen YF; Ryerse JS
    Arch Biochem Biophys; 2003 Feb; 410(2):296-306. PubMed ID: 12573290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.
    Kalkanidis M; Klonis N; Tilley L; Deady LW
    Biochem Pharmacol; 2002 Mar; 63(5):833-42. PubMed ID: 11911834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of action of antimalarial drugs.
    Fitch CD
    Ciba Found Symp; 1983; 94():222-32. PubMed ID: 6341003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine-induced masking of a lipid that promotes ferriprotoporphyrin IX dimerization in malaria.
    Fitch CD; Chen YF; Cai GZ
    J Biol Chem; 2003 Jun; 278(25):22596-9. PubMed ID: 12697766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse membrane-active agents modify the hemolytic response to ferriprotoporphyrin IX.
    Dutta P; Fitch CD
    J Pharmacol Exp Ther; 1983 Jun; 225(3):729-34. PubMed ID: 6602875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
    Famin O; Ginsburg H
    Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems.
    Liu J; Istvan ES; Gluzman IY; Gross J; Goldberg DE
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8840-5. PubMed ID: 16731623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease.
    Goldberg DE; Slater AF; Beavis R; Chait B; Cerami A; Henderson GB
    J Exp Med; 1991 Apr; 173(4):961-9. PubMed ID: 2007860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.